[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369532-105":59,"doc-detail-369532-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","reversing-vtn-deficiency-inhibits-the-progression-of-pancreatic-cancer-and-enhances-sensitivity-to-anti-pd1-immunotherapy","Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy","","Reversing VTN deficiency addresses pancreatic cancer progression and immunotherapy responsiveness by positioning vitronectin (VTN) as a dual-functional regulator. VTN is markedly downregulated in tumor tissues, and lower expression associates with worse overall survival. Integrative analyses of single-cell RNA sequencing, public databases, and functional experiments show that VTN knockdown accelerates proliferation, invasion, and migration, while VTN overexpression suppresses these phenotypes. Immune pathway links support that high VTN predicts improved anti-PD1/PD-L1 outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/reversing-vtn-deficiency-inhibits-the-progression-of-pancreatic-cancer-and-enhances-sensitivity-to-anti-pd1-immunotherapy/369532/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/reversing-vtn-deficiency-inhibits-the-progression-of-pancreatic-cancer-and-enhances-sensitivity-to-anti-pd1-immunotherapy/369532.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main finding about VTN in pancreatic cancer?","Question",{"text":113,"@type":114},"VTN is significantly downregulated in pancreatic cancer tissues, and lower VTN levels correlate with poorer overall survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does changing VTN expression affect pancreatic cancer cells?",{"text":118,"@type":114},"VTN knockdown promotes proliferation, invasion, and migration in vitro, while VTN overexpression suppresses these phenotypes.",{"name":120,"@type":111,"acceptedAnswer":121},"How does VTN relate to immunotherapy response to anti-PD1/PD-L1?",{"text":122,"@type":114},"High VTN levels are associated with improved survival in patients receiving anti-PD1/PD-L1 therapy, and in mice VTN overexpression inhibits tumor growth and synergizes with anti-PD1 treatment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369532,1791164408,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Original Research PUBLISHED 13 May 2025  \nDOI 10.3389/fimmu.2025.1578870  \nOPEN ACCESS  \nEDITED BY  \nClaudine Kieda,  \nMilitary Institute of Medicine, Poland  \nREVIEWED BY  \nJiawei Wang,  \nAir Force Medical University, China Xiong Chen,  \nGuizhou Medical University, China  \n*CORRESPONDENCE  \nMinjie Chen  \n [chenminjiedoctor@163.com](chenminjiedoctor@163.com)[ ](chenminjiedoctor@163.com)Fei Chen  \n [tangchouer@zjxu.edu.cn](tangchouer@zjxu.edu.cn)[ ](tangchouer@zjxu.edu.cn)Zhengwei Song  \n [doctorsongzw@zjxu.edu.cn](doctorsongzw@zjxu.edu.cn)[ ](doctorsongzw@zjxu.edu.cn)†These authors share ﬁrst authorship  \nRECEIVED 18 February 2025  \nACCEPTED 17 April 2025  \nPUBLISHED 13 May 2025  \nCITATION  \nZhao S, Gao Z, Hu L, Li Y, Wang X, Li X, Chen M, Chen F and Song Z (2025)  \nReversing VTN deﬁciency inhibits the progression of pancreatic cancer  \nand enhances sensitivity to anti-PD1 immunotherapy.  \nFront. Immunol. 16:1578870 .  \ndoi: 10.3389/fimmu.2025.1578870  \nCOPYRIGHT  \n© 2025 Zhao, Gao, Hu, Li, Wang, Li, Chen, Chen and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nReversing VTN deﬁciency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy  \nSiqi Zhao 1†, Zhaofeng Gao 1†, Lingyu Hu 1†, Yihan Li 2, Xiaoguang Wang 1, Xiaoping Li 1, Minjie Chen 1*, Fei Chen 1* and Zhengwei Song 1*  \n1 Department of Surgery, The Second Afﬁliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China, 2 Department of Surgery, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China  \nBackground: Pancreatic cancer, a highly lethal malignancy with limited therapeutic options, necessitates the identiﬁcation of novel prognostic biomarkers and therapeutic targets. The extracellular matrix protein vitronectin (VTN) has been implicated in tumor progression, but its speciﬁc role in pancreatic cancer progression and immunotherapy response remains unclear.  \nMethods: This study employed an integrative approach combining single-cell RNA sequencing, analysis of public databases, and functional assays. In vitro experiments assessed the impact of VTN knockdown and overexpression on pancreatic cancer cell proliferation, invasion, and migration. Mechanistic investigations explored associations between VTN expression and immune regulatory factors . A syngeneic mouse subcutaneous tumor model evaluated the therapeutic efﬁcacy of VTN overexpression combined with anti-PD1 immunotherapy.  \nResults: VTN was signiﬁcantly downregulated in pancreatic cancer tissues compared to normal tissues. Lower VTN levels correlated with poorer overall survival. VTN knockdown promoted pancreatic cancer cell proliferation, invasion, and migration in vitro, whereas VTN overexpression suppressed these phenotypes. VTN expression was linked to immune regulatory pathways. High VTN levels predicted improved survival in patients receiving anti-PD1/PD-L1 therapy. In a mouse model, VTN overexpression inhibited tumor growth and synergized with anti-PD1 therapy to enhance antitumor efﬁcacy, suggesting combinatorial therapeutic potential.  \nConclusions: This study identiﬁes VTN as a dual-functional regulator in pancreatic cancer, acting as both a suppressor of tumor progression and a modulator of immunotherapy response. These ﬁndings position VTN as a prognostic biomarker and a therapeutic target to sensitize pancreatic tumors to anti-PD1-based immunotherapy, providing a potential strategy for overcoming treatment resistance in this aggressive malignancy.  \nKEYWORDS  \nvitronectin, pancreatic cancer, tumor progression, immu","cbCaibJM2zm5FzBZ","https://ap.wps.com/l/cbCaibJM2zm5FzBZ","pdf",15121664,14,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the main finding about VTN in pancreatic cancer?\",\"answer\":\"VTN is significantly downregulated in pancreatic cancer tissues, and lower VTN levels correlate with poorer overall survival.\"},{\"question\":\"How does changing VTN expression affect pancreatic cancer cells?\",\"answer\":\"VTN knockdown promotes proliferation, invasion, and migration in vitro, while VTN overexpression suppresses these phenotypes.\"},{\"question\":\"How does VTN relate to immunotherapy response to anti-PD1/PD-L1?\",\"answer\":\"High VTN levels are associated with improved survival in patients receiving anti-PD1/PD-L1 therapy, and in mice VTN overexpression inhibits tumor growth and synergizes with anti-PD1 treatment.\"}]","Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy | PDF",1790183287,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a228f4e19b0361b8a8dc4f224a07cf62.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a07c56a68a277a1b2794931c134acb24.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/191926dc3a0b220e3800ac5a6643158a.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a32b300574a22a623a223dc331d0f6c2.webp",980,1385]